Nigeria, Kenya Ebola Cases May Be Linked to Same Uganda Airport Visit as Officials Intensify Investigation

 By Simpson Global Media News Desk

ABUJA, Nigeria — Thursday, October 22, 2026

African health officials are investigating whether the people at the centre of the first confirmed Ebola cases in Nigeria and Kenya during the current outbreak may have passed through Uganda’s Entebbe International Airport on the same day, raising fresh questions about the virus’s regional movement and the challenge of tracing exposure across international borders.

The Africa Centres for Disease Control and Prevention (Africa CDC) said investigators were examining the possibility that the Nigerian and Kenyan patients crossed paths at the airport on October 3. The possibility remains under investigation; officials have not established that the two patients met, interacted or transmitted the virus to one another. <Cite refs={["turn315138news10","turn575601news14"]}/>

The development comes after Nigeria confirmed an imported case of Bundibugyo Ebola virus disease in the Federal Capital Territory on October 20. The World Health Organization (WHO) said the patient was a woman who had recently travelled from Uganda and was receiving care in isolation in Abuja. The Nigerian government initially reported that 44 contacts had been identified for monitoring. <Cite refs={["turn315138search0","turn575601search1"]}/>

Investigation focuses on international travel

The possibility of a shared airport visit has given investigators another line of inquiry as they work to reconstruct the patients’ movements and determine where exposure may have occurred.

Airports can be challenging environments for disease investigators because travellers may spend limited periods in busy terminals, pass through different areas and continue to other countries before an infection is recognised. Passenger records, travel itineraries, interviews and information from health authorities can help establish whether people were in the same place at the same time.

However, being present at the same airport does not in itself establish contact or transmission. Investigators must determine the relevant timings, locations and possible exposures before drawing conclusions.

According to the Associated Press report published on October 22, Africa CDC officials were examining whether the two patients’ journeys through Entebbe could have involved an interaction. The agency did not announce a confirmed transmission chain between the Nigerian and Kenyan cases. <Cite refs={["turn315138news10"]}/>

What is confirmed about Nigeria’s case?

The Federal Ministry of Health and Social Welfare confirmed the Nigerian infection on October 20 after laboratory testing identified Bundibugyo virus disease.

The WHO African Region reported that the patient’s symptoms began on October 7, four days after her arrival in Nigeria. She sought medical care at a private health facility in Abuja on October 11, and laboratory confirmation followed on October 20.

Health authorities said she was placed in isolation and was receiving medical care. The patient’s likely source of infection and complete travel and exposure history remained under investigation in the WHO’s October 20 update. <Cite refs={["turn315138search0"]}/>

The timeline has made the investigation particularly important. Public-health teams need to identify people who may have been exposed before the diagnosis, assess their level of risk and provide appropriate monitoring and instructions.

The number of people being monitored should not be confused with the number of confirmed infections. The 44 contacts initially reported by Nigerian authorities were people identified for follow-up, not 44 additional Ebola cases. <Cite refs={["turn315138search0","turn315138search2"]}/>

Why the Bundibugyo strain matters

Ebola virus disease is a serious illness that can cause severe symptoms and can be fatal. The current Nigerian case involves the Bundibugyo virus, a distinct species within the group of viruses responsible for Ebola disease.

The strain matters because vaccines and treatments developed for one Ebola virus species cannot automatically be assumed to work against another. WHO has reported that there is no licensed vaccine or specific approved treatment for Bundibugyo virus disease, making early identification, clinical care and infection prevention especially important. <Cite refs={["turn315138search1","turn315138search4"]}/>

Care for suspected or confirmed cases requires trained health workers, appropriate protective equipment, careful handling of potentially infectious materials and suitable isolation arrangements. Facilities must also protect other patients and staff from possible exposure.

Health authorities have therefore emphasised infection prevention and control alongside surveillance and contact tracing. These measures are intended to identify possible transmission early and limit opportunities for further spread. <Cite refs={["turn315138search0","turn315138search2"]}/>

Nigeria intensifies its response

The Nigeria Centre for Disease Control and Prevention (NCDC) has activated its incident-management arrangements to coordinate the national response.

On October 21, the agency convened an incident-management meeting with relevant officials and partners. It said teams were working on the response plan while conducting field activities, including surveillance, contact tracing, infection prevention and control, and public communication. <Cite refs={["turn315138search2"]}/>

The Federal Government has also said it is working with aviation-sector authorities to obtain passenger information and help identify people who may have been exposed during the patient’s journey. Such records can support investigations into flight routes and possible contacts, although passenger lists alone cannot establish who was infected or where transmission occurred. <Cite refs={["turn315138search5"]}/>

The response involves federal health authorities, the NCDC, FCT health officials and international partners, including WHO. Coordination is essential because a person potentially exposed during international travel may live in a different country from the one where the infection is detected.

Regional implications

The investigation is unfolding against a wider outbreak that began in the Democratic Republic of the Congo and has affected several African countries.

Kenya reported nine cases linked to its initial imported case by the October 22 situation reported by the European Centre for Disease Prevention and Control. The agency also recorded Nigeria’s confirmed case and noted that further epidemiological investigations were under way. <Cite refs={["turn315138search4"]}/>

The appearance of cases in countries connected by international travel highlights the importance of communication between national public-health agencies. If a traveller is identified as a possible contact, authorities may need to notify counterparts abroad so that the person can be located and assessed.

Investigators must also establish where exposure most likely occurred rather than relying solely on a traveller’s most recent destination. A recent journey through a country does not, by itself, prove that infection occurred there.

WHO has urged countries to maintain surveillance, rapid investigation of alerts, laboratory capacity and readiness among clinical and response teams. It has also advised against blanket restrictions on travel or trade with affected countries, emphasising evidence-based public-health measures. <Cite refs={["turn315138search0"]}/>

What the public should know

The confirmation of an imported case requires serious attention, but it does not mean that every person in Nigeria is at high risk.

The immediate priority is to identify people who may have been exposed and ensure that suspected infections are assessed quickly. Members of the public should rely on updates from the NCDC, the Federal Ministry of Health and WHO rather than circulating unverified claims about the patient, alleged contacts or the places where transmission may have occurred.

People who have recently travelled to affected areas and develop symptoms that concern them should contact a healthcare professional and clearly explain their travel history. Anyone who believes they may have had a specific exposure should follow instructions from public-health authorities.

Healthcare workers are particularly important to the response. They need accurate travel histories, timely access to appropriate testing and protective equipment, and clear referral procedures for patients who may have Ebola or another serious infectious disease.

The public should not stigmatise travellers, nationalities or communities. Contact tracing is a routine public-health measure intended to identify possible exposure and prevent further transmission, not a basis for blaming individuals or groups.

What happens next?

The investigation is expected to focus on reconstructing the patients’ movements, checking travel records, interviewing relevant contacts and determining whether the airport connection is supported by evidence.

For Nigeria, officials must continue monitoring identified contacts, strengthening infection prevention in healthcare facilities and communicating verified developments to the public. Any newly identified contacts would need assessment and follow-up according to public-health guidance.

As of October 22, the possibility that the Nigerian and Kenyan patients crossed paths at Entebbe International Airport remains an investigative lead, not a confirmed explanation for Nigeria’s infection. The source of the Nigerian patient’s exposure has not been conclusively established in the cited WHO update. <Cite refs={["turn315138news10","turn315138search0"]}/>

The next official updates will be important in clarifying whether investigators establish a connection between the journeys, whether the contact lists change and how the national response develops.

For now, the central public-health priorities remain early detection, accurate information, careful monitoring of contacts and coordinated action across borders. These steps are critical to containing the current outbreak while avoiding speculation that could undermine public confidence or distract from evidence-based response measures.

Sources: World Health Organization Regional Office for Africa, October 20, 2026; Associated Press, October 22, 2026; European Centre for Disease Prevention and Control, October 22, 2026; Nigeria Centre for Disease Control and Prevention reporting published October 21, 2026.